SEP 10, 2018 11:57 AM PDT

The Immune System: A New Hope for Opioid Addiction?

As the death toll for opioid addiction rises to a total of 115 deaths per day average, researchers race to determine the underlying factors that drive these addictions. Opioid addictions result from the overuse of certain pain-relieving medications, heroin, and even fentanyl – a synthetic opioid with extremely high potency. Drug abuse not only hurts the user and their loved ones, but also has economic impacts that include the cost of healthcare, criminal litigation, and time away from work. It is for reasons such as these that we see individuals like Erin Calipari, assistant professor of pharmacology at Vanderbilt University, dedicating their efforts to discovering ways that can combat addiction.

Calipari and her team have recently submitted their research in the Journal of Neuroscience, suggesting there are specific immune system peptides, molecules that are involved in cell signaling, which could have effects on the brains activity and how it relates to addiction. “There are factors within the immune system that are directly changing the way that these brain reward systems drive behavior,” explains Erin. Calipari suggests the immune system may have a degree of control over cravings. Her team has displayed that by altering the immune peptides, they were able to manipulate sugar cravings in murine models.

There are many factors at play with drug addiction which is defined by the NIH National Institute on Drug Abuse defines drug addiction as “a chronic, relapsing brain disease that is characterized by compulsive drug seeking and use, despite harmful consequences.” Calipari is working with Icahn School of Medicine at Mount Sinai to determine how her work can be made useful to human patients.

Vanderbilt recognizes that drug abuse is a public health threat. Calipari hopes that her work intervening in the neurological aspects of the disease will reduce its severity and will help improve how to “define treatment in various populations [of patients].”     

Source: National Institute on Drug Abuse, National Institute on Drug Abuse, The Journal of Neuroscience, YouTube

About the Author
You May Also Like
AUG 04, 2018
Immunology
AUG 04, 2018
Infant's Innate Immune Response
An infant's innate immune response develops from fetus to birth, but it may not be as "immature" as previously thought....
AUG 15, 2018
Immunology
AUG 15, 2018
Therapeutic Macrophages Improve Rare Lung Disorder
The use of therapeutic macrophage transplantation in mice showed great improvement in rare lung disorder caused by deficient macrophages....
AUG 24, 2018
Cell & Molecular Biology
AUG 24, 2018
Chronic Allergies can Change Cells
Chronic rhinosinusitis is different from allergies; it leads to serious inflammation and swelling in the sinuses that can last for years....
OCT 01, 2018
Immunology
OCT 01, 2018
Fate of the T Cell
The immune system consists of a variety of different cell types. But how do the cells undergo differentiation? A study recently published in Science provides insight....
OCT 21, 2018
Immunology
OCT 21, 2018
B -cells Drive auto-T-cells to the Brain
Researchers have provided a paradigm shift in the understanding of auto-reactive T cells in the brain of Multiple Sclerosis patients....
OCT 22, 2018
Immunology
OCT 22, 2018
Barcoding for Cancer Immunity Genes
Scientists develop a novel technology that allows for protein barcoding to reveal gene function...
Loading Comments...